Literature DB >> 1984946

An outbreak of pneumococcal pneumonia in two men's shelters.

A Mercat1, J Nguyen, B Dautzenberg.   

Abstract

We report a retrospective study of 39 homeless men hospitalized for acute pneumonia from April 1988 to March 1989. All of them had recently stayed in one of two shelters. A Streptococcus pneumoniae serotype 1, resistant to cotrimoxazole, was isolated in 29 patients (74 percent). Blood cultures were positive in 24 (61 percent). The patients were relatively young; none was over 70 years old. Thirty-five (90 percent) were heavy smokers; 32 (82 percent) were alcoholics. The radiologic pattern was atypical in 14 cases (36 percent). The only fatal case was linked to the adult respiratory distress syndrome. It is likely that the rate of outbreaks of pneumococcal pneumonia is underestimated. The homeless are at high risk for pneumococcal pneumonia. In addition, the closeness existing in shelters favors the occurrence of outbreaks. Consequently, we suggest that shelter residents would benefit from pneumococcal vaccination.

Entities:  

Mesh:

Year:  1991        PMID: 1984946     DOI: 10.1378/chest.99.1.147

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Authors:  Angela B Brueggemann; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Assessing and Improving Zoster Vaccine Uptake in a Homeless Population.

Authors:  Laura Kaplan-Weisman; Eve Waltermaurer; Casey Crump
Journal:  J Community Health       Date:  2018-12

5.  Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men.

Authors:  Andrew Birtles; Noel McCarthy; Carmen L Sheppard; Harry Rutter; Malcolm Guiver; Elizabeth Haworth; Robert C George
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Quality of published reports of the prognosis of community-acquired pneumonia.

Authors:  C A Carson; M J Fine; M A Smith; L A Weissfeld; J T Huber; W N Kapoor
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

7.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

8.  Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.

Authors:  Otto G Vanderkooi; Deirdre L Church; Judy MacDonald; Franziska Zucol; James D Kellner
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

9.  Epidemic of invasive pneumococcal disease, western Canada, 2005-2009.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Quazi Ibrahim; Sipi Garg; Linda Chui; Tyler J Boone; Carol Mangan; David M Patrick; Linda Hoang; Greg B Horsman; Paul Van Caeseele; Thomas J Marrie
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

10.  Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto.

Authors:  Agron Plevneshi; Tomislav Svoboda; Irene Armstrong; Gregory J Tyrrell; Anna Miranda; Karen Green; Donald Low; Allison McGeer
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.